Home › Funds › LCNB CORP › DOCT
LCNB CORP position in DOCT
FIRST TR EXCHNG TRADED FD VI
LCNB CORP reported holding 114,173 shares of DOCT (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 1.74% of its reported portfolio and ranking #14 among its reported holdings. LCNB CORP has disclosed DOCT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How LCNB CORP's DOCT position evolved
LCNB CORP first disclosed a stake in DOCT in Q3 2024 at 34,935 shares (US$1.4M). The position peaked in Q2 2026 at 122,306 shares, worth US$5.7M. Across 9 filings, LCNB CORP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 114,173 shares valued at US$5.5M — a reduction of -8,133 shares quarter over quarter.. Notable position changes include a 225% increase in Q4 2024 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 34.94K | $1.36M | New |
| Q4 2024 | 113.68K | $4.48M | Add |
| Q1 2025 | 114.28K | $4.38M | Add |
| Q2 2025 | 115.48K | $4.74M | Add |
| Q3 2025 | 124.21K | $5.37M | Add |
| Q4 2025 | 124.26K | $5.50M | Hold |
| Q1 2026 | 127.14K | $5.52M | Add |
| Q2 2026 | 122.31K | $5.71M | Reduce |
| Q3 2026 | 114.17K | $5.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DOCT and 13F data
DOCT (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 31 other funds we track also report a position in DOCT — the largest reported positions include OGOREK ANTHONY JOSEPH /NY/ /ADV (US$13.6M), REAP Financial Group, LLC (US$9.8M), Wood Tarver Financial Group, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DOCT
- OGOREK ANTHONY JOSEPH /NY/ /ADV 283.36K sh · $13.61M · Q3 2026
- REAP Financial Group, LLC 203.71K sh · $9.79M · Q3 2026
- Wood Tarver Financial Group, LLC 176.85K sh · $8.26M · Q2 2026
- Per Stirling Capital Management, LLC. 143.06K sh · $6.87M · Q3 2026
- WINNACLE WEALTH LLC 96.05K sh · $4.61M · Q3 2026
- Foguth Wealth Management, LLC. 87.03K sh · $4.20M · Q3 2026
- Commonwealth Financial Services, LLC 46.50K sh · $2.23M · Q3 2026
- Castleview Partners, LLC 32.36K sh · $1.55M · Q3 2026
FAQ
How long has LCNB CORP held DOCT?
LCNB CORP has disclosed DOCT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is LCNB CORP's current position in DOCT?
As of Q3 2026, LCNB CORP holds 114.17K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $5.49M, representing 1.74% of its reported portfolio and ranking #14.
Has LCNB CORP been buying or selling DOCT?
In the latest 13F filing (Q3 2026), LCNB CORP reduced its position in DOCT. The position peaked in Q2 2026 at 122.31K shares.
Which other funds hold DOCT?
Other major institutional holders of DOCT include OGOREK ANTHONY JOSEPH /NY/ /ADV, REAP Financial Group, LLC, Wood Tarver Financial Group, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.